SCHEMBL25849395

SCHEMBL25849395

COc1cc2c3c(c4c(c2cc1OC)-c1ccc(C(F)(F)F)cc1C4(C)C)C=CC(c1ccc(N2CCOCC2)cc1)(c1ccc(N2CCOCC2)cc1)O3

nearest known ligand 0.34

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TNIK Q9UKE5 1/20 0.34
RAF1 P04049 2/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
ALDH1A1 P00352 2/20 0.33
MAPT P10636 2/20 0.33
HIF1A Q16665 1/20 0.33
PDE10A Q9Y233 2/20 0.32
LMNA P02545 2/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
BRAF P15056 1/20 0.31
MEN1 O00255 1/20 0.31
PKM P14618 1/20 0.31
KMT2A Q03164 1/20 0.31
PDK2 Q15119 1/20 0.31
LCK P06239 1/20 0.31
CHEK1 O14757 2/20 0.31
ULK1 O75385 1/20 0.30
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3962299 0.97 RAF1 (0.35) TNIKRAF1SMN1; SMN2ALDH1A1MAPT
SCHEMBL25605286 0.97 RAF1 (0.33) TNIKRAF1SMN1; SMN2ALDH1A1MAPT
SCHEMBL3953603 0.97 SMN1; SMN2 (0.33) TNIKRAF1SMN1; SMN2ALDH1A1MAPT
SCHEMBL25716497 0.95 TNIK (0.37) TNIKRAF1SMN1; SMN2ALDH1A1MAPT
SCHEMBL25605288 0.93 LMNA (0.36) TNIKRAF1SMN1; SMN2ALDH1A1MAPT
SCHEMBL25716498 0.93 TNIK (0.35) TNIKRAF1SMN1; SMN2ALDH1A1MAPT
SCHEMBL1186527 0.92 MEN1 (0.34) TNIKRAF1SMN1; SMN2ALDH1A1MAPT
SCHEMBL26514172 0.92 NPSR1 (0.35) TNIKRAF1SMN1; SMN2ALDH1A1MAPT
SCHEMBL25716494 0.91 TNIK (0.30) TNIK
SCHEMBL25718161 0.91 LMNA (0.34) RAF1SMN1; SMN2ALDH1A1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4269532-A1 PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND EYEGLASSES Hoya Lens Thailand Ltd. (TH) 2023-11-01 EP disclosed
EP-4270067-A1 PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND GLASSES Hoya Lens Thailand Ltd. (TH) 2023-11-01 EP disclosed
US-20230340318-A1 PHOTOCHROMIC COMPOUND, PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND EYEGLASSES HOYA LENS THAILAND LTD. (TH) 2023-10-26 US disclosed
US-20230227717-A1 PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND SPECTACLES HOYA LENS THAILAND LTD. (TH) 2023-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230340318-A1 PHOTOCHROMIC COMPOUND, PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND EYEGLASSES NR2E3, CRY1, RPS10 TNIK 4867/4885RAF1 2643/4885SMN1; SMN2 3937/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.